Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Body Mass Index and Risk of Colorectal Cancer Incidence and Mortality in Asia Publisher Pubmed



Paragomi P1 ; Zhang Z2 ; Abe SK3 ; Islam MDR3, 4 ; Rahman S3, 5 ; Saito E6 ; Shu XO7 ; Dabo B8 ; Pham YTH1, 2 ; Chen Y9, 10 ; Gao YT11, 12 ; Koh WP13, 14 ; Sawada N15 ; Malekzadeh R16 Show All Authors
Authors
  1. Paragomi P1
  2. Zhang Z2
  3. Abe SK3
  4. Islam MDR3, 4
  5. Rahman S3, 5
  6. Saito E6
  7. Shu XO7
  8. Dabo B8
  9. Pham YTH1, 2
  10. Chen Y9, 10
  11. Gao YT11, 12
  12. Koh WP13, 14
  13. Sawada N15
  14. Malekzadeh R16
  15. Sakata R17
  16. Hozawa A18
  17. Kim J19
  18. Kanemura S18
  19. Nagata C20
  20. You SL21
  21. Ito H22
  22. Park SK23
  23. Yuan JM1, 2
  24. Pan WH24, 25
  25. Wen W7
  26. Wang R1
  27. Cai H18
  28. Tsugane S15
  29. Pourshams A16
  30. Sugawara Y18
  31. Wada K20
  32. Chen CJ26
  33. Oze I27
  34. Shin A23, 28
  35. Ahsan H29
  36. Boffetta P30, 31
  37. Chia KS32
  38. Matsuo K27, 33
  39. Qiao YL34
  40. Rothman N35
  41. Zheng W7
  42. Inoue M3
  43. Kang D23
  44. Luu HN1, 2
Show Affiliations
Authors Affiliations
  1. 1. Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
  2. 2. Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, United States
  3. 3. Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  4. 4. Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  5. 5. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan
  6. 6. Institute for Global Health Policy Research, National Center for Global Health and Medicine, Tokyo, Japan
  7. 7. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States
  8. 8. Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, United States
  9. 9. Department of Population Health, New York University Grossman School of Medicine, New York, United States
  10. 10. Division of Environmental Medicine, New York University Grossman School of Medicine, New York, United States
  11. 11. Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
  12. 12. Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  13. 13. Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  14. 14. Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore
  15. 15. Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  16. 16. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Radiation Effects Research Foundation, Hiroshima, Japan
  18. 18. Tohoku University Graduate School of Medicine, Sendai, Japan
  19. 19. Graduate School of Science and Policy, National Cancer Center, Gyeonggi-Do, South Korea
  20. 20. Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
  21. 21. School of Medicine and Big Data Research Center, Fu Jen Catholic University, New Taipei City, Taiwan
  22. 22. Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
  23. 23. Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea
  24. 24. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
  25. 25. Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan
  26. 26. Genomics Research Center, Academia Sinica, Taipei, Taiwan
  27. 27. Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
  28. 28. Cancer Research Institute, Seoul National University, Seoul, South Korea
  29. 29. Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States
  30. 30. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States
  31. 31. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  32. 32. Saw Swee Hock School of Public Health, National University of Singapore, Singapore
  33. 33. Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  34. 34. Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
  35. 35. Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD, United States

Source: JAMA Network Open Published:2024


Abstract

IMPORTANCE The global burden of obesity is increasing, as are colorectal cancer (CRC) incidence and mortality. OBJECTIVES To assess the association between body mass index (BMI) and risks of incident CRC and CRC-related death in the Asian population. DESIGN, SETTING, AND PARTICIPANTS This cohort study includes data pooled from 17 prospective cohort studies included in The Asia Cohort Consortium. Cohort enrollment was conducted from January 1, 1984, to December 31, 2002. Median follow-up time was 15.2 years (IQR, 12.1-19.2 years). Data were analyzed from January 15, 2023, through January 15, 2024. EXPOSURE Body mass index, calculated as weight in kilograms divided by height in meters squared. MAIN OUTCOMES AND MEASURES The primary outcomes were CRC incidence and CRC-related mortality. The risk of events is reported as adjusted hazard ratios (AHRs) and 95% CIs for incident CRC and death from CRC using the Cox proportional hazards regression model. RESULTS To assess the risk of incident CRC, 619 981 participants (mean [SD] age, 53.8 [10.1] years; 52.0% female; 11 900 diagnosed incident CRC cases) were included in the study, and to assess CRC-related mortality, 650 195 participants (mean [SD] age, 53.5 [10.2] years; 51.9% female; 4550 identified CRC deaths) were included in the study. A positive association between BMI and risk of CRC was observed among participants with a BMI greater than 25.0 to 27.5 (AHR, 1.09 [95% CI, 1.03-1.16]), greater than 27.5 to 30.0 (AHR, 1.19 [95% CI, 1.11-1.29]), and greater than 30.0 (AHR, 1.32 [95% CI, 1.19-1.46]) compared with those with a BMI greater than 23.0 to 25.0 (P < .001 for trend), and BMI was associated with a greater increase in risk for colon cancer than for rectal cancer. A similar association between BMI and CRC-related death risk was observed among participants with a BMI greater than 27.5 (BMI >27.5-30.0: AHR, 1.18 [95% CI, 1.04-1.34]; BMI >30.0: AHR, 1.38 [95% CI, 1.18-1.62]; P < .001 for trend) and was present among men with a BMI greater than 30.0 (AHR, 1.87 [95% CI, 1.49-2.34]; P < .001 for trend) but not among women (P = .15 for trend) (P = .02 for heterogeneity). CONCLUSIONS AND RELEVANCE In this cohort study that included a pooled analysis of 17 cohort studies comprising participants across Asia, a positive association between BMI and CRC incidence and related mortality was found. The risk was greater among men and participants with colon cancer. These findings may have implications to better understand the burden of obesity on CRC incidence and related deaths in the Asian population. © 2024 American Medical Association. All rights reserved.